Target intelligence / Profile preview

Ribosomal protein S27 pseudogene 23 (RPS27P23)

Target: RPS27P23
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein S27 pseudogene 23 (RPS27P23) is a processed pseudogene, related by sequence to the protein-coding RPS27 gene, which encodes a component of the 40S ribosomal subunit. Pseudogenes such as RPS27P23 lack recognized protein products and functional activity, and are not considered druggable or therapeutic targets. There are no known biological functions, disease associations, or drug interactions related to RPS27P23 itself. The parent RPS27 gene has roles in ribosome function, nucleic acid binding, and is implicated in oncogenesis, but the pseudogene RPS27P23 is not functionally characterized nor clinically relevant.

Other names: RPS27P23

Beyond the preview

Go deeper on Ribosomal protein S27 pseudogene 23 (RPS27P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S27 pseudogene 23 (RPS27P23).

Explore the full profile